Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: October 27, 2016
Reporting Period: Third Quarter 2016
This filing serves as a notification that the Company issued a press release announcing its financial results for the third quarter of 2016. The detailed financial data is contained in the press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) incorporated by reference, rather than within the body of this 8-K form.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the attached press release and supplemental website information.
Material Changes
The filing text does not explicitly detail material changes versus the prior comparable period. It only confirms the issuance of results for the third quarter of 2016.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary, risks, contingencies, or unusual items. These details are located in the referenced Exhibit 99.1 (Press Release) and Exhibit 99.2 (Supplemental Information).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q3 2016 revenue, net income, and earnings per share figures.
- Examine Exhibit 99.2 for supplemental data regarding product sales, geographic performance, and R&D pipeline updates.
- Verify any forward-looking statements or guidance adjustments made during the October 27, 2016 announcement.
- Confirm the impact of any currency fluctuations or one-time items mentioned in the full press release.